BATF2 antibody

AP-1 family transcription factor that controls the differentiation of lineage-specific cells in the immune system. Following infection, participates in the differentiation of CD8(+) thymic conventional dendritic cells in the immune system. Acts via the formation of a heterodimer with JUN family proteins that recognizes and binds DNA sequence 5'-TGA[CG]TCA-3' and regulates expression of target genes(By similarity). Selectively suppresses CYR61/CCN1 transcription and hence blocks the downstream cell proliferation signals produced by CYR61 and inhibits CYR61-induced anchorage-independent growth and invasion in several cancer types, such as breast cancer, malignant glioma and metastatic melanoma. Possibly acts by interfering with AP-1 binding to CYR61 promoter.

Basic leucine zipper transcriptional factor ATF-like 2 (B-ATF-2)|Suppressor of AP-1 regulated by IFN (SARI)|BATF2

116071

Q8N1L9

Rabbit

Human

basic leucine zipper transcription factor, ATF-like 2

BATF2

Polyclonal

IgG

ELISAA, WB, IP

Epigenetics, Metabolism

Immunogen affinity purified

WB: 1:200-1:1000; IP: 1:200-1:1000

≥95% as determined by SDS-PAGE

Liquid

29 kDa

PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20°C for 12 months(Avoid repeated freeze / thaw cycles.)

Primary Antibodies

https://www.fn-test.com/product/FNab00808/

Hela cells were subjected to SDS PAGE followed by western blot with FNab00808 (BATF2 antibody) at dilution of 1:500